Initial results of efficacy and safety of Sofosbuvir among Pakistani Population: A real life trialHepatitis Eradication Accuracy Trial of Sofosbuvir (HEATS)

Authors

  • Zahid Azam Dow University of Health Sciences, Karachi
  • Muhammad Shoaib Memom medical Institute Hospital.
  • Masood Javed Punjab medical collage Faisalabad
  • Muhammad Adnan Sarwar DHQ Hospital Faisalabad
  • Hafeezullah Shaikh National Institute of liver & GI Diseases NILGID),Dow University Hospital
  • Nasir Khokhar Shifa International Hospital Shifa Tameer e Millat University Islamabad

DOI:

https://doi.org/10.12669/pjms.331.12352

Keywords:

Sofosbuvir, HCV infection, Rapid virologic response (RVR).

Abstract

Objective: The uridine nucleotide analogue sofosbuvir is a selective inhibitor of hepatitis C virus (HCV) NS5B polymerase approved for the treatment of chronic HCV infection with genotypes 1

Downloads

Additional Files

Published

2017-02-21

How to Cite

Azam, Z., Shoaib, M., Javed, M., Sarwar, M. A., Shaikh, H., & Khokhar, N. (2017). Initial results of efficacy and safety of Sofosbuvir among Pakistani Population: A real life trialHepatitis Eradication Accuracy Trial of Sofosbuvir (HEATS). Pakistan Journal of Medical Sciences, 33(1). https://doi.org/10.12669/pjms.331.12352

Issue

Vol. 33 No. 1 (2017): January – February 2017 Pak J Med Sci

Section

Original Articles